AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On June 12, 2025,
(SMR) experienced a significant drop in trading volume, with a 42.6% decrease from the previous day, totaling 7.53 billion. This decline placed NuScale at the 101st position in the daily stock market rankings. The stock price of NuScale Power (SMR) fell by 2.93%.Certrec, a leading provider of regulatory compliance and advanced SaaS applications for the nuclear industry, has announced its continued support for NuScale Power in submitting and achieving U.S. Nuclear Regulatory Commission approval for Revision 2 of NuScale’s Standard Design Approval (SDA) application. This milestone marks a significant chapter in the long-standing collaboration between Certrec and NuScale for its cutting-edge small modular reactor (SMR) design. Certrec first supported NuScale in 2012 during the development of its initial Design Certification Application (DCA). Revision 2 of the SDA reflects critical design enhancements and licensing updates that aid NuScale’s ongoing deployment efforts.
Certrec’s expertise streamlined the submission process for NuScale’s small modular reactor design, saving time and money. Carrie Fosaaen, Vice President of Regulatory Affairs and Services at NuScale Power, expressed pride in having Certrec as a trusted partner in developing licensing applications for over a decade. Their support has been invaluable in bringing NuScale’s small modular reactor technology to market. Certrec’s role in the development and management of the SDA Revision 2 application included project oversight, document processing, and regulatory support. Certrec digitized and expedited the application process through Taktix®, its SaaS workflow solution, enabling NuScale’s team to focus on technical content development while keeping documentation protected and organized.
Hunt down the stocks with explosive trading volume.

Dec.05 2025

Dec.05 2025

Dec.05 2025

Dec.05 2025

Dec.05 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet